DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 17.590
- +0.020+0.11%
Close Feb 14 16:00 ET
- 17.590
- 0.0000.00%
Post 17:01 ET
1.33BMarket Cap-6.11P/E (TTM)
18.020High17.180Low663.75KVolume17.670Open17.570Pre Close11.64MTurnover1.06%Turnover RatioLossP/E (Static)75.89MShares29.56052wk High2.53P/B1.10BFloat Cap10.16552wk Low--Dividend TTM62.79MShs Float52.380Historical High--Div YieldTTM4.78%Amplitude4.220Historical Low17.535Avg Price1Lot Size
About Nurix Therapeutics Company
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Company Profile
SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees286
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Arthur T. Sands, M.D.,PhD
- Director, President and Chief Executive Officer
- 4.36M
- Dr. Gwenn Hansen, PhD
- Chief Scientific Officer
- 1.63M
- Dr. Christine Ring, J.D.,PhD
- Chief Legal Officer, Chief Compliance Officer and Secretary
- --
- Hans van Houte
- Chief Financial Officer and Principal Accounting Officer
- 1.61M
- Julia P. Gregory
- Chairman of the Board
- 238.29K
- Anil Kapur
- Director
- --
- Judith A. Reinsdorf, J.D.
- Independent Director
- 225.79K
- Dr. David L. Lacey, M.D.
- Independent Director
- 263.29K
- Paul M. Silva
- Independent Director
- 225.79K
- Dr. Lori Anne Kunkel, M.D.
- Independent Director
- 228.29K
- Edward C. Saltzman
- Independent Director
- 223.29K